Hebervis

N/A

Report date: 2022/02/21 11:04:39

Base Information

Drug NameHebervis
Drug Alias NameCGIB-400
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionEpidermal growth factor receptor erbB1 antagonists
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsStomatitisColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCenter For Genetic Engineering And Biotechnology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCenter For Genetic Engineering And Biotechnology
Active IndicationsN/A
Inactive IndicationsStomatitisColitis, Ulcerative

Other Information

ATC CodeN/A
Related LinksN/A